E. Piaggio et al., Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats, PARASIT RES, 87(7), 2001, pp. 539-547
Because benznidazole (BZL) was found to downregulate nitric oxide (NO) and
cytokine synthesis by murine macrophages, we analyzed the potential immunol
ogical repercussions of BZL treatment in Trypanosoma cruzi-infected rats. T
o evaluate whether the effects of BZL were also observed in the presence of
an immunostimulating cytokine, four groups of acutely infected rats were s
ubjected to one of the following 20-day therapeutic schedules: (1) a curati
ve BZL oral regimen, (2) recombinant interferon (IFN-gamma) injections, (3)
a suboptimal BZL regimen (25 % of curative dose), (4) the latter plus IFN-
gamma. All BZL doses markedly reduced NO-derived metabolites either in the
circulation or in cultured macrophage supernatants. This was observed in ra
ts simultaneously treated with IFN-gamma, which contrasted with the augment
ed NO production seen in animals given this cytokine alone. The untreated r
ats, and groups receiving monotherapy with IFN-gamma or 25% BZL, had increa
sed circulating interleukin (IL)-1 beta and IL-2 levels, which were reduced
in those given BZL plus IFN-gamma. Although combined treatment failed to c
ause the virtually undetectable blood parasite levels induced by optimal BZ
L doses, chronic myocardial lesions were reduced to the same extent as in t
hose receiving the curative schedule. The beneficial effects of BZL in this
trypanosomiasis may also depend on some immunomodulating influences.